INTERCEPT PHARMACEUTICALS, INC. short interest in 2020
In 2020, INTERCEPT PHARMACEUTICALS, INC.'s disclosed short interest ran from 14.93% of shares outstanding on 15 Jan 2020 to 22.20% on 31 Dec 2020, a change of +7.27 percentage points. The year's high was 22.20% on 31 Dec 2020 and its low 13.48% on 31 Mar 2020, averaging 16.77% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.60 days on 14 Feb 2020. Full history: INTERCEPT PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2020 in figures
- Start of year
- 14.93% (15 Jan 2020)
- End of year
- 22.20% (31 Dec 2020)
- Change
- +7.27 pp
- High
- 22.20% (31 Dec 2020)
- Low
- 13.48% (31 Mar 2020)
- Average
- 16.77%
- Highest days to cover
- 13.60 (14 Feb 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 14.93% | 8.44 | |
| 31 Jan 2020 | 15.30% | 8.22 | |
| 14 Feb 2020 | 14.56% | 13.60 | |
| 28 Feb 2020 | 14.95% | 9.32 | 10-K filed, results (8-K) |
| 13 Mar 2020 | 14.35% | 8.25 | |
| 31 Mar 2020 | 13.48% | 6.57 | |
| 15 Apr 2020 | 13.70% | 10.43 | |
| 30 Apr 2020 | 15.11% | 9.26 | |
| 15 May 2020 | 16.63% | 8.35 | 10-Q filed, results (8-K) |
| 29 May 2020 | 17.57% | 6.16 | |
| 15 Jun 2020 | 17.60% | 10.77 | |
| 30 Jun 2020 | 19.46% | 4.43 | |
| 15 Jul 2020 | 17.85% | 5.76 | |
| 31 Jul 2020 | 17.94% | 7.91 | |
| 14 Aug 2020 | 16.70% | 6.47 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 15.67% | 9.26 | |
| 15 Sep 2020 | 16.74% | 7.98 | |
| 30 Sep 2020 | 19.45% | 11.62 | |
| 15 Oct 2020 | 18.15% | 7.31 | |
| 30 Oct 2020 | 16.88% | 7.26 | |
| 13 Nov 2020 | 15.89% | 4.88 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 17.64% | 10.91 | |
| 15 Dec 2020 | 19.76% | 8.65 | |
| 31 Dec 2020 | 22.20% | 6.60 |
See also: INTERCEPT PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.